M, V. R., Gnk, G., B, B., Jagadeesan, R., & M R, P. K. (2022). Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration: Risk assessment of CGT and PC Exclusivity drugs. Acta Marisiensis - Seria Medica, 68(1). https://doi.org/10.2478/amma-2022-0004